Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 192 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

Hypercholesterolemia Phase 3 United States

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Rotator Cuff Tendinopathy Phase 3 United States
Italy
Greece
Spain
Poland
Hungary
China
Denmark
View All

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

IC-MPGN Phase 3 United States
Turkey
Spain
Italy
United Kingdom
Brazil
Germany
Switzerland
Argentina
Japan
Israel
Vietnam
France
Canada
Poland
Czech Republic
View All

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

Uncomplicated Plasmodium Falciparum Malaria Phase 2 Kenya
Côte D'Ivoire
Uganda
Ghana
View All

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Newly Diagnosed and Recurrent Glioblastoma Phase 1 Spain
Israel
Portugal

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease Phase 3

The Belgian REAL (BE.REAL) Registry

Atherosclerotic Cardiovascular Disease Belgium

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Rotator Cuff Tendinopathy Phase 3 United States
Turkey
Slovakia
Czech Republic
Argentina
France
Portugal
United Kingdom
Canada
Chile
Bulgaria
View All

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

Non-Small-Cell Lung Carcinoma Korea, Republic of

Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

Breast Cancer France